Literature DB >> 3953714

Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data.

R Yancik, L G Ries, J W Yates.   

Abstract

With use of a unique data set from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute for 11,062 women diagnosed with ovarian cancer from 1973 to 1982, this study focuses on the impact of old age on this malignancy. Aspects of ovarian cancer as it pertains especially to elderly women (those 65 years or older) are examined according to age/stage relationships at initial diagnosis and age variations in treatment and survival. Elderly women are more likely than younger women to be in advanced stages of ovarian cancer at initial diagnosis, and they constitute about 42% of this group. In the stage-unknown category, over 50% are 65 years or older. Data suggest that elderly women are treated more conservatively than younger patients. The National Cancer Institute data also illustrate the increased preference to treat this neoplasm with surgical procedures and chemotherapy rather than surgical procedures and radiation. For Stages III and IV disease, 5-year relative survival rates for elderly women are almost one half of the rate observed for women under 65. Although the prognosis of patients with advanced ovarian tumors is poor for all, it is even worse as age progresses.

Entities:  

Mesh:

Year:  1986        PMID: 3953714     DOI: 10.1016/0002-9378(86)90623-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

Review 1.  Drug therapy for gynaecological cancer in older women.

Authors:  R E van Rijswijk; J B Vermorken
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography.

Authors:  Daniel Polsky; Katrina A Armstrong; Thomas C Randall; Richard N Ross; Orit Even-Shoshan; Paul R Rosenbaum; Jeffrey H Silber
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

3.  Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma.

Authors:  María José García-Velloso; Matías Jurado; Carolina Ceamanos; José Manuel Aramendía; María Puy Garrastachu; Guillermo López-García; José Angel Richter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-21       Impact factor: 9.236

4.  Endometrial and Ovarian Cancer with MR Imaging Importance of Serum HE4 and CA 125 Levels in the Extent of Disease at Evaluation.

Authors:  Emsal Pınar Topdağı Yılmaz; Yakup Kumtepe
Journal:  Eurasian J Med       Date:  2016-10

5.  [Geriatric surgery in gynecology].

Authors:  C Anthuber
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

6.  Is ovarian cancer undertreated in older women?

Authors:  D L Marchetti; M M Hreshchyshyn
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

7.  Feasibility and safety of extensive upper abdominal surgery in elderly patients with advanced epithelial ovarian cancer.

Authors:  Myong Cheol Lim; Sokbom Kang; Yong Jung Song; Sae Hyun Park; Sang-Yoon Park
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

8.  Risk-scoring model for prediction of non-home discharge in epithelial ovarian cancer patients.

Authors:  Mariam M AlHilli; Christine W Tran; Carrie L Langstraat; Janice R Martin; Amy L Weaver; Michaela E McGree; Andrea Mariani; William A Cliby; Jamie N Bakkum-Gamez
Journal:  J Am Coll Surg       Date:  2013-06-29       Impact factor: 6.113

9.  Determination of serum CRP, VEGF, Leptin, CK-MB, CA-15-3 and IL-6 levels for malignancy prediction in adnexal masses.

Authors:  Serhat Sen; Oğuzhan Kuru; Ozgür Akbayır; Hilal Oğuz; Vildan Yasasever; Sinan Berkman
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

10.  Production of nitric oxide and expression of inducible nitric oxide synthase in ovarian cystic tumors.

Authors:  Rosekeila Simões Nomelini; Lívia Carolina de Abreu Ribeiro; Beatriz Martins Tavares-Murta; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Mediators Inflamm       Date:  2009-01-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.